Anthony Skene

Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial

Ian E. Smith, Mitch Dowsett, S. Ebbs et al. · Journal of Clinical Oncology · 2005 · 772 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer

Mitch Dowsett, Ian E. Smith, S. Ebbs et al. · JNCI Journal of the National Cancer Institute · 2007 · 666 citations · Full text

Medicine, Oncology, Pharmacology +17

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer

Isaac García-Murillas, Neha Chopra, Iñaki Comino‐Méndez et al. · JAMA Oncology · 2019 · 428 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Short-Term Changes in Ki-67 during Neoadjuvant Treatment of Primary Breast Cancer with Anastrozole or Tamoxifen Alone or Combined Correlate with Recurrence-Free Survival

Mitch Dowsett, Ian E. Smith, Steve R. Ebbs et al. · Clinical Cancer Research · 2005 · 350 citations · Full text

Medicine, Oncology, Pharmacology +13

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

Ian Smith, J.F.R. Robertson, Lucy Kilburn et al. · The Lancet Oncology · 2020 · 317 citations · Full text

Medicine, Oncology, Pharmacology +17